NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Index- P/E17.82 EPS (ttm)0.75 Insider Own0.95% Shs Outstand496.46M Perf Week-3.33%
Market Cap6.63B Forward P/E14.03 EPS next Y0.95 Insider Trans0.96% Shs Float491.95M Perf Month5.78%
Enterprise Value10.54B PEG2.95 EPS next Q0.20 Inst Own100.90% Short Float5.32% Perf Quarter26.78%
Income373.00M P/S1.50 EPS this Y-7.67% Inst Trans2.01% Short Ratio4.29 Perf Half Y8.45%
Sales4.43B P/B1.04 EPS next Y13.22% ROA2.77% Short Interest26.17M Perf YTD10.24%
Book/sh12.80 P/C13.61 EPS next 5Y6.04% ROE6.01% 52W High18.55 -28.03% Perf Year-26.49%
Cash/sh0.98 P/FCF19.11 EPS past 3/5Y- 29.95% ROIC3.48% 52W Low8.02 66.46% Perf 3Y-36.19%
Dividend Est.- EV/EBITDA11.76 Sales past 3/5Y-2.33% 7.65% Gross Margin43.10% Volatility1.64% 1.78% Perf 5Y-39.51%
Dividend TTM- EV/Sales2.38 EPS Y/Y TTM128.55% Oper. Margin5.40% ATR (14)0.44 Perf 10Y-
Dividend Ex-Date- Quick Ratio1.46 Sales Y/Y TTM1.42% Profit Margin8.43% RSI (14)53.72 Recom1.79
Dividend Gr. 3/5Y- - Current Ratio2.71 EPS Q/Q109.77% SMA20-1.86% Beta1.68 Target Price14.82
Payout0.00% Debt/Eq0.69 Sales Q/Q-1.00% SMA5013.55% Rel Volume0.62 Prev Close13.46
Employees9450 LT Debt/Eq0.68 EarningsMay 07 BMO SMA2009.15% Avg Volume6.10M Price13.35
IPOSep 20, 2018 Option/ShortYes / Yes EPS/Sales Surpr.20.80% 2.02% Trades Volume3,755,650 Change-0.82%
Date Action Analyst Rating Change Price Target Change
Dec-09-24Initiated UBS Buy $18
Dec-02-24Initiated Leerink Partners Market Perform $14
Sep-19-24Downgrade Morgan Stanley Overweight → Equal-Weight $17 → $15
Jan-05-24Upgrade Stifel Hold → Buy $13 → $20
Dec-19-23Initiated Jefferies Buy $17
Dec-15-23Upgrade Morgan Stanley Equal-Weight → Overweight $16
Dec-07-23Initiated Exane BNP Paribas Outperform $18
Apr-20-23Upgrade Barclays Equal Weight → Overweight $14
Aug-18-22Downgrade Morgan Stanley Overweight → Equal-Weight $37 → $22
Aug-16-22Downgrade JP Morgan Overweight → Neutral $28 → $24
Jun-18-25 12:46PM
Jun-12-25 04:17PM
Jun-11-25 04:25AM
Jun-10-25 12:00PM
11:40AM
09:40AM Loading…
09:40AM
Jun-09-25 08:48AM
Jun-05-25 07:45AM
May-28-25 11:00AM
07:25AM
May-20-25 12:00AM
May-16-25 08:00AM
May-12-25 06:45PM
May-08-25 03:09AM
01:47AM
12:53PM Loading…
May-07-25 12:53PM
12:52PM
09:30AM
08:36AM
07:35AM
06:27AM
May-05-25 04:40PM
06:27AM
May-01-25 10:01AM
Apr-30-25 10:01AM
Apr-28-25 09:07AM
Apr-23-25 05:45PM
12:24PM
Apr-22-25 12:50PM
11:25AM
11:34AM Loading…
Apr-10-25 11:34AM
08:00AM
Apr-08-25 10:30AM
Apr-04-25 10:00AM
Mar-31-25 07:33AM
Mar-28-25 04:55PM
Mar-26-25 11:02AM
Mar-21-25 07:52AM
Mar-19-25 10:27AM
Mar-18-25 05:01AM
Mar-17-25 04:17PM
Mar-14-25 05:03AM
Mar-13-25 08:44AM
Mar-11-25 11:05PM
Feb-26-25 06:09PM
02:05AM
12:34AM
Feb-25-25 01:38PM
01:15PM
09:30AM
08:20AM
07:15AM
07:05AM
07:05AM
Feb-24-25 09:16AM
08:05AM
Feb-21-25 08:00AM
Feb-20-25 12:05PM
08:27AM
Feb-13-25 04:29PM
Feb-10-25 12:17PM
Feb-04-25 08:00AM
Feb-03-25 12:18AM
Jan-30-25 02:45PM
Jan-27-25 08:06AM
Jan-23-25 08:27AM
Jan-12-25 09:38AM
Jan-10-25 12:30PM
Dec-19-24 11:07AM
Dec-01-24 09:08AM
Nov-29-24 12:18PM
Nov-27-24 01:45PM
Nov-26-24 07:22AM
04:31AM
Nov-25-24 08:45AM
08:00AM
Nov-24-24 11:33AM
Nov-23-24 07:23AM
Nov-21-24 10:46AM
Nov-20-24 08:53AM
Nov-18-24 02:52PM
Nov-15-24 11:30AM
Nov-14-24 03:15PM
Nov-13-24 01:39PM
Nov-12-24 07:20PM
08:33AM
05:45AM
Nov-11-24 04:02PM
Nov-08-24 04:03AM
02:09AM
02:03AM
Nov-07-24 04:30PM
03:28PM
12:41PM
09:30AM
08:52AM
07:35AM
06:27AM
Nov-05-24 07:38AM
Nov-04-24 03:51PM
Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. Its products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, TruCan, AviPro, Baytril, Catosal, Denagard, and Experior. The company was founded in 1954 and is headquartered in Greenfield, IN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kurzius Lawrence ErikDirectorMar 07 '25Buy10.9010,000109,000101,459Mar 11 05:13 PM
Kurzius Lawrence ErikDirectorMar 11 '25Buy10.2010,000102,000111,459Mar 11 05:13 PM
HOOVER R DAVIDDirectorMar 05 '25Buy10.9025,000272,558210,000Mar 07 04:21 PM
Harrington Michael JDirectorAug 22 '24Buy14.853,50051,97481,094Aug 26 05:05 PM
Simmons Jeffrey NPRESIDENT, CEO AND DIRECTORAug 12 '24Buy13.01100,0001,300,610145,000Aug 13 09:04 AM